Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly common autoimmune disease.

Finerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first ...

ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of ...

A shocking new study reveals nearly half of adults with diabetes have no idea they're living with this potentially deadly condition ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

Type 1 diabetes is a condition that currently has no cure, only palliative treatments such as insulin administration and, in ...

People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including ...

Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact ...

GLP-1 RA use was associated with improved cardiometabolic outcomes among pediatric patients with type 2 diabetes and obesity.

A large real-world analysis of 1.8 million patients found that type 2 diabetes patients with sleep apnea gained a 20% greater survival benefit from GLP-1 therapy than those without.

Diabetes is becoming more and more common in the United States. New data from the Centers for Disease Control and Prevention (CDC) shows that nearly 16% of American adults—about one in every six—now ...